Alveolar Bone Marrow as a Cell Source for Regenerative Medicine: Differences Between Alveolar and Iliac Bone Marrow Stromal Cells
Top Cited Papers
Open Access
- 1 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 20 (3) , 399-409
- https://doi.org/10.1359/jbmr.041117
Abstract
We isolated and expanded BMSCs from human alveolar/jaw bone at a high success rate (70%). These cells had potent osteogenic potential in vitro and in vivo, although their chondrogenic and adipogenic potential was less than that of iliac cells. Introduction: Human bone marrow stromal cells (BMSCs) have osteogenic, chondrogenic, and adipogenic potential, but marrow aspiration from iliac crest is an invasive procedure. Alveolar BMSCs may be more useful for regenerative medicine, because the marrow can be aspirated from alveolar bone with minimal pain. Materials and Methods: In this study, alveolar bone marrow samples were obtained from 41 patients, 6–66 years of age, during the course of oral surgery. BMSCs were seeded and maintained in culture with 10% FBS and basic fibroblast growth factor. In addition, BMSCs were induced to differentiate into osteoblasts, chondrocytes, or adipocytes in appropriate medium. Results and Conclusion: From a small volume (0.1–3 ml) of aspirates, alveolar BMSCs expanded at a success ratio of 29/41 (70%). The success rate decreased with increasing donor age, perhaps because of age-dependent decreases in the number and proliferative capacity of BMSCs. The expanded BMSCs differentiated into osteoblasts under osteogenic conditions in 21–28 days: the mRNA levels of osteocalcin, osteopontin, and bone sialoprotein, along with the calcium level, in alveolar BMSC cultures were similar to those in iliac cultures. However, unlike iliac BMSC, alveolar BMSC showed poor chondrogenic or adipogenic potential, and similar differences were observed between canine alveolar and iliac BMSCs. Subsequently, human alveolar BMSCs attached to β-tricalcium phosphate were transplanted into immunodeficient mice. In transplants, new bone formed with osteoblasts and osteocytes that expressed human vimentin, human osteocalcin, and human GAPDH. These findings suggest that BMSCs have distinctive features depending on their in vivo location and that alveolar BMSCs will be useful in cell therapy for bone diseases.Keywords
This publication has 34 references indexed in Scilit:
- Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftmentBlood, 2004
- Cell Therapy for Bone Disease: A Review of Current StatusThe International Journal of Cell Cloning, 2003
- Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stromaProceedings of the National Academy of Sciences, 2003
- Mesenchymal Stem Cells in Perichondrium Express Activated Leukocyte Cell Adhesion Molecule and Participate in Bone Marrow FormationThe Journal of Experimental Medicine, 2002
- Retention of Multilineage Differentiation Potential of Mesenchymal Cells during Proliferation in Response to FGFBiochemical and Biophysical Research Communications, 2001
- Mesenchymal stem cellsExperimental Hematology, 2000
- Age-Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone MarrowJournal of Bone and Mineral Research, 1999
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Normal Human Cementum-Derived Cells: Isolation, Clonal Expansion, and In Vitro and In Vivo CharacterizationJournal of Bone and Mineral Research, 1998
- A Direct Spectrophotometric Microassay for Sulfated Glycosaminoglycans in Cartilage CulturesConnective Tissue Research, 1982